Product NDC: | 42023-104 |
Proprietary Name: | Aplisol |
Non Proprietary Name: | tuberculin purified protein derivative |
Active Ingredient(s): | 5 [iU]/.1mL & nbsp; tuberculin purified protein derivative |
Administration Route(s): | INTRADERMAL |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42023-104 |
Labeler Name: | JHP Pharmaceuticals LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA001781 |
Marketing Category: | BLA |
Start Marketing Date: | 20080207 |
Package NDC: | 42023-104-01 |
Package Description: | 1 mL in 1 VIAL (42023-104-01) |
NDC Code | 42023-104-01 |
Proprietary Name | Aplisol |
Package Description | 1 mL in 1 VIAL (42023-104-01) |
Product NDC | 42023-104 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | tuberculin purified protein derivative |
Dosage Form Name | INJECTION |
Route Name | INTRADERMAL |
Start Marketing Date | 20080207 |
Marketing Category Name | BLA |
Labeler Name | JHP Pharmaceuticals LLC |
Substance Name | TUBERCULIN PURIFIED PROTEIN DERIVATIVE |
Strength Number | 5 |
Strength Unit | [iU]/.1mL |
Pharmaceutical Classes | Skin Test Antigen [EPC],Tuberculosis Skin Test [EPC],Cell-mediated Immunity [PE],Antigens, Bacterial [Chemical/Ingredient] |